| _version_ | 1866901849155567616 |
|---|---|
| author | Hopkins, Chris Gemine, Rachel Farrington, Stephen Yeung, Ng |
| author_facet | Hopkins, Chris Gemine, Rachel Farrington, Stephen Yeung, Ng |
| contents | <p>Prostate cancer is the most commonly diagnosed male cancer in the UK. Data from the National Prostate Cancer Audit 2020 shows a 23% rise in annual prostate cancer diagnoses from 2017 and Welsh Cancer Intelligence Surveillance Unit data shows that across Wales, 3,192 men were diagnosed with prostate cancer in 2018. Of these, 454 patients (14.2%) were from Hywel Dda University Health Board (HDdUHb), even though the health board represents only 10% of Wales’s population.</p> <p>The clinical pathway redesign was supported by patient and public involvement and previous mapping of the clinical pathways. The introduction of a weekly prostate specific MRI session (Tuesday morning) at Bronglais General Hospital, Aberystwyth, allowed up to four patients on the PROSTAD pathway (from across all parts of <br>the Health Board) to be scanned. All eligible patients are invited onto the PROSTAD pathway, dependent upon the availability of MRI slots at Bronglais Hospital and the patient’s availability to attend the MRI appointment. Reporting on scans was to be undertaken within 24 hours such that they were available on Wednesday afternoon when the patients were invited for an appointment, either face to face or by phone depending on patient preference.</p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_18418448 |
| institution | Zenodo |
| language | eng |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | PROSTAD - The development of a Model Prostate Cancer Diagnostic Pathway Hopkins, Chris Gemine, Rachel Farrington, Stephen Yeung, Ng <p>Prostate cancer is the most commonly diagnosed male cancer in the UK. Data from the National Prostate Cancer Audit 2020 shows a 23% rise in annual prostate cancer diagnoses from 2017 and Welsh Cancer Intelligence Surveillance Unit data shows that across Wales, 3,192 men were diagnosed with prostate cancer in 2018. Of these, 454 patients (14.2%) were from Hywel Dda University Health Board (HDdUHb), even though the health board represents only 10% of Wales’s population.</p> <p>The clinical pathway redesign was supported by patient and public involvement and previous mapping of the clinical pathways. The introduction of a weekly prostate specific MRI session (Tuesday morning) at Bronglais General Hospital, Aberystwyth, allowed up to four patients on the PROSTAD pathway (from across all parts of <br>the Health Board) to be scanned. All eligible patients are invited onto the PROSTAD pathway, dependent upon the availability of MRI slots at Bronglais Hospital and the patient’s availability to attend the MRI appointment. Reporting on scans was to be undertaken within 24 hours such that they were available on Wednesday afternoon when the patients were invited for an appointment, either face to face or by phone depending on patient preference.</p> |
| title | PROSTAD - The development of a Model Prostate Cancer Diagnostic Pathway |
| url | https://doi.org/10.5281/zenodo.18418448 |